Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors.

@article{Tomimaru2015ClinicalUO,
  title={Clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors.},
  author={Yoshito Tomimaru and Hidetoshi Eguchi and Mitsuaki Tatsumi and Tonsok Kim and Naoki Hama and Hiroshi Wada and Koichi Kawamoto and Shogo Kobayashi and Eiichi Morii and Masaki Mori and Yuichiro Doki and Hiroaki Nagano},
  journal={Surgery},
  year={2015},
  volume={157 2},
  pages={269-76}
}
BACKGROUND Pancreatic neuroendocrine tumors (PNETs) present various histologic stages, and their clinical behavior ranges from benign to highly aggressive. World Health Organization (WHO) grading categorizes PNETs into 3 groups (G1, G2, and G3) based on proliferative activity. The aim of this study was to assess the clinical utility of 2-[(18)F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in preoperative differential diagnosis for various histologic grades of PNETs and in… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 29 references

WHO classification of tumors of the digestive system (World Health Organization Classification of Tumors)

  • FT Bosman, F Carneiro, RH Hruban, ND. Theise
  • 2010
Highly Influential
6 Excerpts

Similar Papers

Loading similar papers…